Investor mix
7 investors on record; lead investors include Perceptive Advisors, Andera Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Provider of antisense oligonucleotides for the treatment of rare muscular genetic disorder
7 investors on record; lead investors include Perceptive Advisors, Andera Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 1 | 14% |